𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiosurgery versus carbon dioxide laser for dermatochalasis correction in Asians

✍ Scribed by Carol S. Yu; Henry H.L. Chan; Raymond K.K. Tse


Book ID
102467975
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
185 KB
Volume
39
Category
Article
ISSN
0196-8092

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background and Objectives

Carbon dioxide (CO~2~) laser and radiosurgery are techniques commonly employed in oculoplastic surgery. However, there is no literature comparing their results in blepharoplasty.

Study Design/Materials and Methods

Twenty Chinese patients with dermatochalasis underwent radiosurgery in one upper eyelid and CO~2~ laser in the contralateral eyelid. Intraoperative time, hemorrhage, and pain control were assessed. Subjects were evaluated at postoperative 1 hour, 1 week, 1 month, and 3 months for hemorrhage and wound healing by a masked assessor.

Results

All patients reported minimal pain with either technique. A significantly shorter operative time was achieved with CO~2~ laser, with better intraoperative hemostasis. There was no significant difference in postoperative hemorrhage and wound swelling between radiosurgery and CO~2~ laser. No significant intraoperative complications were noted.

Conclusions

Both radiosurgery and CO~2~ laser are equally safe and effective for upper lid blepharoplasty. CO~2~ laser achieves shorter operative time with superior intraoperative hemostasis. Lasers Surg. Med. 39:176–179, 2007. Β© 2007 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Fractional ablative carbon dioxide laser
✍ Nicola P.Y. Chan; Stephanie G.Y. Ho; Chi K. Yeung; Samantha Y.N. Shek; Henry H. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 253 KB πŸ‘ 1 views

## Abstract ## Background and Objectives Ablative fractional resurfacing (AFR) is a new modality for photorejuvenation and acne scars which combines carbon dioxide (CO~2~) laser ablation with fractional photothermolysis. The objective is to evaluate the efficacy and side effects of a new fractiona